Business
Nanodropper now operating as Mu Medical, a precision eyecare platform
Developer of the volume-reducing eye drop bottle adaptor consolidates with Bedo Solutions and Viseon Labs into a commercial-stage medtech ecosystem.
Legal
VA optometrists secure physician-level pay parity
Reform bill changes include increased pay awards, bonuses, and annual evaluations to help close current OD recruitment and retention gap.
Research
GLP-1 use may lower long-term DME, DR risk
Study highlights protective effect of GLP-1 RAs against ocular complications of diabetes and disparities for racialized patients
Pipeline
Complement Therapeutics secures Fast Track Designation for lead GA therapy
AAV-based CTx001 modulates multiple pathways of the complement system when delivered as a one-time, subretinal injection.
Pipeline
FDA approves Allotex's IDE for US study of tissue-based solution for presbyopia
Company gets all-clear for clinical trial on its tissue addition technology and customized, laser-shaped human corneal tissue to restore vision.
Pipeline
Aviceda releases phase 2b topline data on AVD-104 for GA
Latest SIGLEC trial results show both dosing arms with 31% to 38% less lesion growth than prior trials; phase 3 plans are underway.
Business
STAAR Surgical and Alcon terminate proposed merger
Decision to end the estimated $1.6 billion deal follows a failed vote among STAAR stockholders earlier this week.
Events
Registration opens for the American Retina Forum with Eyes On Eyecare 2026
First-time virtual collaboration invites the next generation of retinal specialists to hear from leading clinical experts and claim CME credits.
Products
Euclid Vision launches new SiHy daily disposable lens for myopia
The Be Free Day soft lens for pediatric myopes features BHVI's proprietary dual action, multistep optical design technology.
Products
FDA approves Gland Pharma's OTC Extra Strength Pataday generic
Olopatadine HCl ophthalmic solution 0.7% is indicated to temporarily relieve itchy eyes due to pollen, ragweed, grass, animal hair, and dander for 24 hours.
Research
Study identifies key risk factors for punctate inner choroidopathy patients
Study identifies key risk factors for punctate inner choroidopathy patients.
Pipeline
FDA grants Breakthrough Therapy Designation to Oculis' privosegtor for optic neuritis
The neuroprotective candidate is currently being studied in the global PIONEER clinical program for both acute ON and NAION.
Products
FDA clears first EDOF contact lens for presbyopia
U.S. approval is first for a daily disposable, extended-depth-of-field lens requiring no patient cognitive adaptation period for presbyopia correction.
Products
FDA approves Formycon and Bioeq's Lucentis biosimilar
Nufymco (ranibizumab-leyk) marks the companies’ second ranibizumab biosimilar cleared in the U.S. to treat five retinal indications.
Pipeline
FDA rejects Outlook Therapeutics' third BLA submission of bevacizumab for wet AMD
Agency cites need for confirmatory evidence of efficacy as reason for latest CRL; ONS-5010 is already approved in the EU and UK as LYTENAVA.
Research
Does YAG capsulotomy increase DR risk?
Study highlights need for close monitoring of NPDR patients after posterior capsule opacification treatment.
Pipeline
FDA accepts Viridian's veligrotug BLA for TED
Therapeutic also receives priority review, enabling a PDUFA target action date for the end of June 2026.
Pipeline
What to keep an eye on in 2026
A new year means new clinical data and NDA submissions—get the full rundown.
Events
Happy New Year!
A word from the Glance editorial team.
Events